SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $854,000 | +196.5% | 27,291 | +44.6% | 0.28% | +575.6% |
| Q1 2016 | $288,000 | -68.1% | 18,871 | -70.7% | 0.04% | -52.9% |
| Q3 2015 | $903,000 | -18.4% | 64,396 | -1.2% | 0.09% | -19.4% |
| Q2 2015 | $1,107,000 | -36.2% | 65,169 | -54.6% | 0.11% | -36.5% |
| Q1 2015 | $1,735,000 | -49.4% | 143,529 | -65.3% | 0.17% | -48.0% |
| Q4 2014 | $3,432,000 | +285.2% | 413,512 | +303.4% | 0.33% | +324.7% |
| Q3 2014 | $891,000 | – | 102,515 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |